Drugs / TIV
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00192322 Comparator | Sep → Dec 2001 | influenza | MedImmune LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00192322 ↗ |
| Modality | Vaccine | “commercially available injectable trivalent influenza vaccine (TIV)” NCT00192322 ↗ |
| Route | Intramuscular | “injected intramuscularly” NCT00192322 ↗ |